Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer von Niemeijer, A. N., Leung, D., Huisman, M. C., Bahce, I., Hoekstra, O. S., van Dongen, G. A. M. S., Boellaard, R., Du, S., Hayes, W., Smith, R., Windhorst, A. D., Hendrikse, N. H., Poot, A., Vugts, D. J., Thunnissen, E., Morin, P., Lipovsek, D., Donnelly, D. J., Bonacorsi, S. J., Velasquez, L. M., de Gruijl, T. D., Smit, E. F., de Langen, A. J.

Volltext

Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs von Van der Veldt, Astrid A.M., Lubberink, Mark, Bahce, Idris, Walraven, Maudy, de Boer, Michiel P., Greuter, Henri N.J.M., Hendrikse, N. Harry, Eriksson, Jonas, Windhorst, Albert D., Postmus, Pieter E., Verheul, Henk M., Serné, Erik H., Lammertsma, Adriaan A., Smit, Egbert F.

Volltext

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo von Kortekaas, Rudie, Leenders, Klaus L., van Oostrom, Joost C. H., Vaalburg, Willem, Bart, Joost, Willemsen, Antoon T. M., Hendrikse, N. Harry

Volltext

Development of [11C]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status von BAHCE, Idris, SMIT, Egbert F, LAMMERTSMA, Adriaan A, HARRY HENDRIKSE, N, LUBBERINK, Mark, VAN DER VELDT, Astrid A. M, YAQUB, Maqsood, WINDHORST, Albert D, SCHUIT, Robert C, THUNNISSEN, Erik, HEIDEMAN, Daniëlle A. M, POSTMUS, Pieter E

Volltext

Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials? von Jauw, Yvonne W S, Menke-van der Houven van Oordt, C Willemien, Hoekstra, Otto S, Hendrikse, N Harry, Vugts, Danielle J, Zijlstra, Josée M, Huisman, Marc C, van Dongen, Guus A M S

Volltext

ABCG2- and ABCB1 Inhibition Using Supratherapeutic Doses of Erlotinib: Clinical Implications in the Treatment of Central Nervous System Metastases von van de Stadt, Eveline A, Yaqub, Maqsood, Bahce, Idris, Hendrikse, N H

Volltext

Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients von Bartelink, I H, van de Stadt, E A, Leeuwerik, A F, Thijssen, V L J L, Hupsel, J R I, van den Nieuwendijk, J F, Bahce, I, Yaqub, M, Hendrikse, N H

Volltext

Needs for information and reasons for (non)adherence in chronic myeloid leukaemia: Be aware of social activities disturbing daily routines von Boons, Christel C. L. M., Harbers, Lorette, Timmers, Lonneke, de Jong, Jan, Swart, Eleonora L., Harry Hendrikse, N., Janssen, Jeroen J. W. M., Hugtenburg, Jacqueline G.

Volltext

Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radic... von Bodar, Yves J. L., Zwezerijnen, Ben G. J. C., van der Voorn, Patrick J., Jansen, Bernard H. E., Smit, Ruth S., Kol, Sabrine Q., Meijer, Dennie, de Bie, Katelijne, Yaqub, Maqsood, Windhorst, Bert A. D., Hendrikse, Harry N. H., Vis, André N., Oprea-Lager, Daniela E.

Volltext

A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma von El-Khouly, Fatma E., Veldhuijzen van Zanten, Sophie E. M., Jansen, Marc H. A., Bakker, Dewi P., Sanchez Aliaga, Esther, Hendrikse, N. Harry, Vandertop, W. Peter, van Vuurden, Dannis G., Kaspers, Gertjan J. L.

Volltext

Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer von Jansen, Bernard HE, Cysouw, Matthijs CF, Vis, André N, van Moorselaar, Reindert JA, Voortman, Jens, Bodar, Yves JL, Schober, Patrick R, Hendrikse, N Harry, Hoekstra, Otto S, Boellaard, Ronald, Oprea-Lager, DE

Volltext

Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET von Bahce, I, Yaqub, M, Smit, E.F, Lammertsma, A.A, van Dongen, G.A.M.S, Hendrikse, N.H

Volltext

In Vivo Evaluation of P-Glycoprotein Modulation of 8 PET Radioligands Used Clinically von Ishiwata, Kiichi, Kawamura, Kazunori, Yanai, Kazuhiko, Hendrikse, N. Harry

Volltext

Pharmaceutical and clinical development of phosphonate-based radiopharmaceuticals for the targeted treatment of bone metastases von Lange, Rogier, ter Heine, Rob, (FF) Knapp, Russ, de Klerk, John M.H, Bloemendal, Haiko J, Hendrikse, N. Harry

Volltext

Tolerability of tariquidar – A third generation P-gp inhibitor as add-on medication to antiseizure medications in drug-resistant epilepsy von Ilyas-Feldmann, Maria, Langer, Oliver, Bauer, Martin, Asselin, Marie-Claude, Hendrikse, N. Harry, Sisodiya, Sanjay M., Duncan, John S., Löscher, Wolfgang, Koepp, Matthias

Volltext

CYP3A4 inhibitors do not influence [68Ga]Ga-DOTA-TATE uptake in liver tissue von Chahid, Youssef, Chahid, Faouzi, van de Garde, Ewoudt, Booij, Jan, Verberne, Hein J., Hendrikse, N. Harry

Volltext

Simplified Methods for Quantification of 18F-DCFPyL Uptake in Patients with Prostate Cancer von Jansen, Bernard HE, Yaqub, Maqsood, Voortman, Jens, Cysouw, Matthijs CF, Windhorst, Albert D, Schuit, Robert C, Kramer, Gerbrand M, van den Eertwegh, Alfons JM, Schwarte, Lothar A, Hendrikse, N Harry, Vis, André N, van Moorselaar, Reindert JA, Hoekstra, Otto S, Boellaard, Ronald, Oprea-Lager, Daniela E

Volltext

Management impact of 18F-DCFPyL PET/CT in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective study von Meijer, Dennie, van Leeuwen, Pim J., Oosterholt, Pepijn M. J., Bodar, Yves J. L., van der Poel, Henk G., Hendrikse, N. Harry, Donswijk, Maarten L., Wondergem, Maurits, Vellekoop, Annelies E., van Moorselaar, R. Jeroen A., Nieuwenhuijzen, Jakko A., Oprea-Lager, Daniela E., Vis, André N.

Volltext

Standardised uptake values as determined on prostate‐specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients... von Bodar, Yves J.L., Veerman, Hans, Meijer, Dennie, de Bie, Katelijne, van Leeuwen, Pim J., Donswijk, Maarten L., van Moorselaar, R. Jeroen A., Hendrikse, N. Harry, Boellaard, Ronald, Oprea‐Lager, Daniela E., Vis, André N.

Volltext

Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib von Boons, Christel C. L. M., Timmers, Lonneke, Janssen, Jeroen J. W. M., Westerweel, Peter E., Blijlevens, Nicole M. A., Smit, Willem M., Bartelink, Imke H., Wilschut, Janneke A., Swart, Eleonora L., Hendrikse, N. Harry, Hugtenburg, Jacqueline G.

Volltext